Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial
Douglass A. Morrison(Southern Arizona VA Health Care System), Daniel J. Lewis, Venki Paramesh(University of Arizona), Stuart B. Pett, Steven P. Sedlis, Kodangudi B. Ramanathan, Sarah M. Vernon, Frederick G.P. Welt(Harvard University), Vladimir Birjiniuk, Jerome Sacks(Edward Hines, Jr. VA Hospital), David T. Booth(Google (United States)), Charles Barbiere, Tamim Antakli, Gulshan K. Sethi(University of Arizona), John C. Lucke, Jorge Saucedo, William G. Henderson(University of Colorado Denver), Mitchell W. Krucoff(Duke University), Frederick L. Grover(University of Colorado Denver), Sundeep Mediratta, Walter G. Wolfe(Duke University), Darryl S. Weiman
Cited by 307
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
|European Heart Journal|2011|1.2k
Independent Association between Acute Renal Failure and Mortality following Cardiac Surgery
|The American Journal of Medicine|1998|1.2k
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
|Circulation|2018|926
Adv. Drug Delivery Rev.
|Advanced Drug Delivery Reviews|1997|863